retatrutide blindness the wonder drug: What's Established, What's Plausible, What's Still a Hypothesis — WellFounded - Founders Health & Concierge Performance Medicine RETA RATS ASSEMBLE , #medicine
Description
M., Adzhigirey, M., Day, T., Annabhimoju, R
C., Soler, M
For metformin users, the MHRA recommends periodic monitoring, especially in those with symptoms suggestive of B12 deficiency
As the field evolves, its crucial for healthcare leaders and organizations to stay agile, adapt to new trends, and focus on what matters most for patients and providers, namely: GLP1s are now firstline therapies: Adoption has accelerated from just 3% in 2021 to more than 23% in 2025, displacing longstanding generics like metformin
(ASCO Post, 2024)
309, R795R804
